ESPERION THERAPEUTICS INC NE
ESPR·29664W105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
ESPR (ESPERION THERAPEUTICS INC NE) is held by 108 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($48.9M), WASATCH ADVISORS LP ($43.2M), VANGUARD CAPITAL MANAGEMENT LLC ($28.6M). Net institutional sentiment: Mixed.
108
Holders
Avg rating(29 Elite)
$344.1M
Total Value
54% (119)
Fund Consensus
62 buying - 52 selling
Who's Trading
InsiderKLKoenig Sheldon L.Sell $169KJun 17, 2026
InsiderHBHalladay BenjaminSell $34KJun 17, 2026
InsiderLBLooker BenjaminSell $37KJun 17, 2026
ActivistGLGlazer Capital, LLC8.2%Jun 8, 2026
InsiderKLKoenig Sheldon L.Sell $70KMar 17, 2026
InsiderHBHalladay BenjaminSell $17KMar 17, 2026
InsiderLBLooker BenjaminSell $15KMar 17, 2026
InsiderLBLooker BenjaminSell $5KJan 20, 2026
13F: Insider & Congress:
Showing 1-20 of 119
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer